Brief: Stayble Therapeutics Q2 EBIT Loss Widens To SEK 6.9 Mln
22/08/2023 07:18
Aug 22 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q2 EBIT LOSS SEK 6.9 MILLION VERSUS LOSS SEK 6.6 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr4rPnPz
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln